Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma Cash from Operations (TTM): -13.66M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -13.66M |
December 31, 2023 | -14.35M |
September 30, 2023 | -13.63M |
June 30, 2023 | -14.06M |
March 31, 2023 | -13.20M |
December 31, 2022 | -12.77M |
September 30, 2022 | -12.14M |
June 30, 2022 | -12.78M |
March 31, 2022 | -11.77M |
Date | Value |
---|---|
December 31, 2021 | -10.59M |
September 30, 2021 | -10.12M |
June 30, 2021 | -8.328M |
March 31, 2021 | -7.093M |
December 31, 2020 | -5.652M |
September 30, 2020 | -4.792M |
June 30, 2020 | -2.453M |
March 31, 2020 | -2.405M |
December 31, 2019 | -2.128M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-14.35M
Minimum
Dec 2023
-2.128M
Maximum
Dec 2019
-9.551M
Average
-11.18M
Median
Cash from Operations (TTM) Benchmarks
Eyenovia Inc | -26.77M |
Cassava Sciences Inc | -87.90M |
Alpine Immune Sciences Inc | -80.55M |
Clearside Biomedical Inc | -18.77M |
Poseida Therapeutics Inc | -69.30M |